Product Literature
Brief Description |
HERmark™ Breast Cancer Assay is a CLIA-validated, quantitative assay, based on VeraTag™ technology, that measures HER2 total protein and HER2 homodimer levels. It is intended for use with formalin-fixed paraffinembedded (FFPE) tumor specimens |